Alessandro Ciarcia: Connecting Expertise and Innovation to Transform the Future of TTP Management at ISTH 2026
Alessandro Ciarcia, Marketing Director at Sanofi, shared a post on LinkedIn:
“Excited to be at ISTH 2026, where the global thrombosis and hemostasis community comes together to share knowledge, challenge ideas, and drive progress for patients.
One of the greatest values of this meeting is the opportunity to engage in meaningful conversations with leading experts, clinicians, researchers, and industry partners who are advancing our understanding of thrombotic thrombocytopenic purpura (TTP)—a rare, life-threatening disease where continued collaboration, innovation, and scientific exchange can have a meaningful impact on patient outcomes.
Looking forward to learning from the latest science, exchanging perspectives, and building connections that help move the field forward.”
Stay Updated with the Latest ISTH 2026 Updates on Hemostasis Today.
-
Aug 31, 2026, 05:19Tania Ahuja: Apixaban in Abdominal Transplant Patients
-
Aug 31, 2026, 04:28Reza Hafidz Irawan։ Automated Antibody Titration With Erytra Eflexis
-
Aug 31, 2026, 04:17Safa Chenganath: Stenosis vs Thrombosis – Hemodialysis Vascular Access
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session
-
Aug 30, 2026, 17:02David McGlasson: A 2020 Article Reaches 8,000 Reads